China is investing heavily in cutting-edge genetic experiments. It’s part of their quest to become a biotech superpower.
On today’s Big Take Asia Podcast, host K. Oanh Ha, Bloomberg’s Karoline Kan and Oxford University geneticist Andy Greenfield discuss China’s pharmaceutical ambitions and the loose regulatory environment that allows the animal testing industry to thrive.
Read more: China Pushes Boundaries With Animal Testing to Win Global Biotech Race

The Sixth Bureau Episode 6: Nothing Is Holy
35:08

Reopening the Straight of Hormuz Is Going to Take Awhile
14:34

The Iran War Is the Fed's Worst Nightmare
17:17